EC Healthcare (HK:2138)
:2138
2138 Stock Chart & Stats
HK$0.57
-HK$0.01(-1.61%)
At close: 4:00 PM EST
HK$0.57
-HK$0.01(-1.61%)
Day’s Range― - ―
52-Week RangeHK$0.44 - HK$1.20
Previous CloseN/A
Volume263.00K
Average Volume (3M)629.78K
Market Cap
HK$604.46M
Enterprise ValueHK$1.35B
Total Cash (Recent Filing)HK$1.07B
Total Debt (Recent Filing)HK$1.34B
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Jun 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.72%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,185,211,300
10 Day Avg. Volume673,306
30 Day Avg. Volume629,783
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.46
Price to Sales (P/S)0.20
P/FCF Ratio1.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.02
Revenue Forecast (FY)HK$5.02B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GrowthConsistent free cash flow growth and a high free-cash-flow-to-net-income ratio indicate the business can generate real cash despite accounting losses. Over 2–6 months this provides liquidity for clinic operations, targeted reinvestment and working-capital needs without immediate reliance on new financing.
High Gross Profit MarginAn 80.7% gross margin reflects strong unit economics typical of service-based medical offerings. If management controls operating expenses, this margin cushion supports long-term profitability recovery and scalable incremental revenue, improving leverage on incremental volumes over months.
Diversified Clinic Service MixA diversified clinic network offering preventive, vaccination and aesthetic services spreads revenue across recurring preventive care and elective services. This mix supports steadier patient flows and cross-selling opportunities, helping stabilize revenue and utilization over the medium term.
Bears Say
Large Revenue DeclineA nearly 30% revenue drop is a durable headwind that erodes operating leverage and makes fixed-cost absorption harder. Over several months this impairs margin recovery, limits reinvestment capacity into clinics and services, and raises the bar for sustainable turnaround execution.
Negative Return On EquityNegative ROE signals the company is not converting equity capital into profitable returns. Structurally this implies capital allocation or operational issues that, if unresolved, will constrain shareholder value creation and hamper the company's ability to attract long-term equity funding or justify expansion.
Operating Cash Shortfall Vs. Net LossesWith operating cash covering less than half of accounting losses and declining EBIT/EBITDA margins, the business risks continued erosion of cash buffers if profitability isn't restored. Over months this pressures liquidity, restricts capex or marketing, and could force cost cutting or external financing.
EC Healthcare News
2138 FAQ
What was EC Healthcare’s price range in the past 12 months?
EC Healthcare lowest stock price was HK$0.43 and its highest was HK$1.20 in the past 12 months.
What is EC Healthcare’s market cap?
EC Healthcare’s market cap is HK$604.46M.
When is EC Healthcare’s upcoming earnings report date?
EC Healthcare’s upcoming earnings report date is Jun 18, 2026 which is in 73 days.
How were EC Healthcare’s earnings last quarter?
EC Healthcare released its earnings results on Nov 28, 2025. The company reported -HK$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.009.
Is EC Healthcare overvalued?
According to Wall Street analysts EC Healthcare’s price is currently Overvalued.
Does EC Healthcare pay dividends?
EC Healthcare pays a Annually dividend of HK$0.01 which represents an annual dividend yield of 1.72%. See more information on EC Healthcare dividends here
What is EC Healthcare’s EPS estimate?
EC Healthcare’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EC Healthcare have?
EC Healthcare has 1,185,211,300 shares outstanding.
What happened to EC Healthcare’s price movement after its last earnings report?
EC Healthcare reported an EPS of -HK$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.667%.
Which hedge fund is a major shareholder of EC Healthcare?
Currently, no hedge funds are holding shares in HK:2138
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EC Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-19.02%
12-Months-Change
Fundamentals
Return on Equity
-10.08%
Trailing 12-Months
Asset Growth
-6.44%
Trailing 12-Months
Company Description
EC Healthcare
EC Healthcare, an investment holding company, engages in the provision of medical and healthcare services in Hong Kong, Macau, and the People's Republic of China. The company operates through three segments: Medical, Aesthetic Medical and Beauty and Wellness, and Others. It provides quasi-medical, beauty and wellness, medical imaging, medical surgery, aesthetic medical beauty, aesthetic medical, dental, hair treatment, vaccine, chiropractic, psychological, and orthopedics services. It also offers administrative, management, laboratory testing, performance marketing, marketing, and travel agency services; sells beauty and skincare products; operates in healthcare machines and property investment holding businesses; and provides multi-channel networking and related services, and veterinary services. The company offers products and services primarily under private-label brands, such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. The company was formerly known as Union Medical Healthcare Limited and changed its name to EC Healthcare in April 2021. EC Healthcare was founded in 2005 and is headquartered in Mong Kok, Hong Kong.
Technical Analysis
Natural Beauty Bio-Technology
―
China Ludao Technology Co. Ltd.
―
Shanghai Chicmax Cosmetics Co., Ltd. Class H
―
Giant Biogene Holding Co. Ltd.
―
Nanjing Sinolife United Co., Ltd. Class H
―
Options Prices
Currently, No data available
---